Harte-Hanks (NYSE: HHS) reported Q2 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $97.3 million versus the consensus estimate of $116.25 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.